Effects of repeated oral postnatal exposure to chlorpyrifos on open-field behavior in juvenile rats

被引:62
作者
Carr, RL
Chambers, HW
Guarisco, JA
Richardson, JR
Tang, J
Chambers, JE
机构
[1] Mississippi State Univ, Coll Vet Med, Ctr Environm Hlth Sci, Mississippi State, MS 39762 USA
[2] Mississippi State Univ, Dept Entomol & Plant Pathol, Mississippi State, MS 39762 USA
关键词
acetylcholinesterase (AChE); neural developmental aberrations; chlorpyrifos; development; behavior; motor activity;
D O I
10.1093/toxsci/59.2.260
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Organophosphorus (OP) insecticides have the potential to cause behavioral effects in children. This study was designed to determine if repeated oral exposure of preweanling rats to chlorpyrifos would produce behavioral changes at both pre- and postweanling ages. Treatment occurred every second day beginning on postnatal day (PND) 1, and continued through PND 21. The rats received one of the following regimens: a low-dosage (3 mg/kg) from PND 1-21; a medium dosage (mg/kg from PND 1-5, and then 6 mg/kg from PND 7-21; or a high-dosage schedule of 3 mg/kg on PND 1-5, then 6 mg/kg from PND 7-13, and 12 mg/kg from PND 15-21. There were no differences in body weights among the control-, low-, and medium-dosage groups but the high-dosage group had significantly lower body weights on PND 13-21. An open field was used to measure locomotor activity on PND 10, 12, 14, 16, 18, 20, 25, and 30. There were no differences in locomotor activity levels or treatment effects between males and females. On PND 10, 12, 14, 16, 18, and 20 there was no effect on locomotor activity with any dosage. On days 25 and 30, locomotor activity was significantly decreased with the medium- and high-dosage groups. Brain cholinesterase (ChE) inhibition mas about 25-38% on PND 25 and 14-34% on PND 30. On PND 25 but not 30, lung and diaphragm ChE and serum butyrylcholinesterase (BChE), with the high-dosage animals, and heart ChE with the medium- and high-dosage groups were significantly inhibited. There was no significant inhibition of skeletal muscle ChE or serum acetylcholinesterase (AChE) on PND 25 and 30. These data suggest that early postnatal chlorpyrifos exposures will depress locomotor activity in juvenile rats, with the effects most pronounced after brain ChE activity has substantially recovered.
引用
收藏
页码:260 / 267
页数:8
相关论文
共 34 条
[1]   Age-related differences in parathion and chlorpyrifos toxicity in male rats: Target and nontarget esterase sensitivity and cytochrome P450-mediated metabolism [J].
Atterberry, TT ;
Burnett, WT ;
Chambers, JE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1997, 147 (02) :411-418
[2]   The effects of neonatal basal forebrain lesions on cognition: Towards understanding the developmental role of the cholinergic basal forebrain [J].
Berger-Sweeney, J .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1998, 16 (7-8) :603-612
[3]  
BUSHNELL PJ, 1994, J PHARMACOL EXP THER, V270, P15
[4]  
BUSHNELL PJ, 1993, J PHARMACOL EXP THER, V266, P1007
[5]   Early expression of ubiquitin in myofibers of rats in organophosphate intoxication [J].
Calore, EE ;
Sesso, A ;
Puga, FR ;
Cavaliere, MJ ;
Calore, NMP ;
Weg, R .
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 1999, 43 (02) :187-194
[6]   Chlorpyrifos interferes with cell development in rat brain regions [J].
Campbell, CG ;
Seidler, FJ ;
Slotkin, TA .
BRAIN RESEARCH BULLETIN, 1997, 43 (02) :179-189
[7]   COMPARATIVE NEUROCHEMICAL AND NEUROBEHAVIORAL EFFECTS OF REPEATED CHLORPYRIFOS EXPOSURES IN YOUNG AND ADULT-RATS [J].
CHAKRABORTI, TK ;
FARRAR, JD ;
POPE, CN .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 46 (01) :219-224
[8]  
CHAMBERS JE, 1988, NEUROSCI RES COMMUN, V3, P85
[9]   COMPARATIVE DEVELOPMENTAL AND MATERNAL NEUROTOXICITY FOLLOWING ACUTE GESTATIONAL EXPOSURE TO CHLORPYRIFOS IN RATS [J].
CHANDA, SM ;
HARP, P ;
LIU, J ;
POPE, CN .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1995, 44 (02) :189-202
[10]   Neurochemical and neurobehavioral effects of repeated gestational exposure to chlorpyrifos in maternal and developing rats [J].
Chanda, SM ;
Pope, CN .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 53 (04) :771-776